Michael Gray
2017 - X4 Pharmaceuticals
In 2017, Michael Gray earned a total compensation of $856.7K as Chief Operating Officer and Chief Financial Officer at X4 Pharmaceuticals, a 9% increase compared to previous year.
Compensation breakdown
| Bonus | $231,525 |
|---|---|
| Option Awards | $262,090 |
| Salary | $363,077 |
| Total | $856,692 |
Gray received $363.1K in salary, accounting for 42% of the total pay in 2017.
Gray also received $231.5K in bonus and $262.1K in option awards.
Rankings
In 2017, Michael Gray's compensation ranked 9,724th out of 14,666 executives tracked by ExecPay. In other words, Gray earned more than 33.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,724 out of 14,666 | 34th |
Division Manufacturing | 3,759 out of 5,772 | 35th |
Major group Chemicals And Allied Products | 1,304 out of 2,075 | 37th |
Industry group Drugs | 1,052 out of 1,731 | 39th |
Industry Biological Products, Except Diagnostic Substances | 187 out of 313 | 40th |
Source: SEC filing on April 23, 2018.
Gray's colleagues
We found six more compensation records of executives who worked with Michael Gray at X4 Pharmaceuticals in 2017.
2017
René BCPS
X4 Pharmaceuticals
Chief Executive Officer
2017
René Russo
X4 Pharmaceuticals
Chief Executive Officer
2017
Paula Ragan
X4 Pharmaceuticals
Chief Executive Officer
2017
Christopher Stevens
X4 Pharmaceuticals
Chief Medical Officer
2017
Chris Stevens
X4 Pharmaceuticals
Chief Medical Officer
2017
David Mantus
X4 Pharmaceuticals